NCT06580691

Brief Summary

Both male and female patients, with atrophic acne scars All patients underwent one session of subcision before receiving: A: cog PDO threads on one side of the face (one session). B: plasma gel on the other side (one session). Primary outcomes: clinical improvements reported by physicians. Secondary out come: satisfaction levels of patients.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
20

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Jan 2023

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

January 1, 2023

Completed
6 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 30, 2023

Completed
5 months until next milestone

Study Completion

Last participant's last visit for all outcomes

December 5, 2023

Completed
9 months until next milestone

First Submitted

Initial submission to the registry

August 26, 2024

Completed
4 days until next milestone

First Posted

Study publicly available on registry

August 30, 2024

Completed
Last Updated

August 30, 2024

Status Verified

August 1, 2024

Enrollment Period

6 months

First QC Date

August 26, 2024

Last Update Submit

August 29, 2024

Conditions

Keywords

Acne vulgarisAtrophic acne scarsThreadsPolydioxanonePlasma gel

Outcome Measures

Primary Outcomes (4)

  • Clinical improvement

    The improvement was assessed using the Goodman and Baron scale.

    after 3 month of the procedure

  • Clinical improvement

    The improvement was assessed using the ECCA grading scale.

    after 3 month of the procedure

  • Clinical improvement

    The improvement was assessed using the physician global assessment.

    after 3 month of the procedure

  • Clinical improvement

    The improvement was assessed using the FASQoL questionnaire to assess the effect on patients quality of life.

    after 3 month of the procedure

Secondary Outcomes (2)

  • Patients satisfaction.

    3 months from the procedure

  • Side effects of the procedures.

    During 3 months from the procedure

Study Arms (2)

Subcision plus Plasma gel

ACTIVE COMPARATOR

The gel was injected into the scarred areas immediately after subcision.

Procedure: Subcision plus Plasma gel injection Vs Subcision plus Cog PDO threads

Subcision plus Cog PDO threads

ACTIVE COMPARATOR

Cog PDO threads were inserted using a blunt-tipped cannula in a "Z pattern" within the scarred areas, filling the pockets created by subcision.

Procedure: Subcision plus Plasma gel injection Vs Subcision plus Cog PDO threads

Interventions

Plasma Gel: was injected into the scarred areas immediately after subcision. Thread Treatment: Cog PDO threads were inserted using a blunt-tipped cannula in a "Z pattern" within the scarred areas, filling the pockets created by subcision.

Subcision plus Cog PDO threadsSubcision plus Plasma gel

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Patients over 18 years old, with atrophic acne scars on both sides of their faces of any severity.

You may not qualify if:

  • patients with keloidal tendencies or bleeding disorders.
  • Participants with a history of recent isotretinoin use within 3 months
  • Patients who underwent any procedure for treatment of acne scars during the last 6 months.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Department of Dermatology and Venereology, Faculty of Medicine, Tanta University

Tanta, Gharbia Governorate, 31527, Egypt

Location

MeSH Terms

Conditions

Acne Vulgaris

Condition Hierarchy (Ancestors)

Acneiform EruptionsSkin DiseasesSkin and Connective Tissue DiseasesSebaceous Gland Diseases

Study Officials

  • Wael Saudi, MD

    Misr University for Science and Technology

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
SINGLE GROUP
Model Details: both male and female patients with atrophic acne scars
Sponsor Type
OTHER
Responsible Party
SPONSOR INVESTIGATOR
PI Title
Lecturer

Study Record Dates

First Submitted

August 26, 2024

First Posted

August 30, 2024

Study Start

January 1, 2023

Primary Completion

June 30, 2023

Study Completion

December 5, 2023

Last Updated

August 30, 2024

Record last verified: 2024-08

Data Sharing

IPD Sharing
Will not share

Locations